chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Extra dose administered, Headache, Nausea, Palpitations
Clinical narrative: Heart palpitations, close to fainting (room appeared getting dark), swelling sensation in throat, severe headache, nausea, chills.  Symptoms began 12 minutes after receiving the COVID-19 Moderna booster. 50 cc?s of liquid  benedryl was given  as treatment as well as kept me in the urgent care to monitor my heart rhythm and oxygen level for approximately two and a half hours.  Then discharged.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Presyncope
Clinical narrative: Heart palpitations, close to fainting (room appeared getting dark), swelling sensation in throat, severe headache, nausea, chills.  Symptoms began 12 minutes after receiving the COVID-19 Moderna booster. 50 cc?s of liquid  benedryl was given  as treatment as well as kept me in the urgent care to monitor my heart rhythm and oxygen level for approximately two and a half hours.  Then discharged.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Headache
Clinical narrative: Stomach ache and headache on 11/16/2021 and 11/17/2021
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Pain
Clinical narrative: Swollen and painful lymph node in the right armpit. Pain started the night of the shot and progressed. The greatest pain and largest swelling was at 48 hours and persisted for the next day (total of 72 hours) at day 4 the swelling had started to subside and pain was dulling. The node was normal (or at least felt normal) by day 6. Just treated it at home with a heat pack, gentle massage, water, and ibuprofen. Was painful enough to affect sleep but not enough to seek professional help.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site mass, Injection site pain, Injection site pruritus
Clinical narrative: day of injection - sore arm day after injection - arm more sore (took advil)  pain at injection site, very itchy, red, swollen lump 2nd day after injection - hard lump at injection site, red, skin warm to touch
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Injection site warmth, Pain in extremity
Clinical narrative: day of injection - sore arm day after injection - arm more sore (took advil)  pain at injection site, very itchy, red, swollen lump 2nd day after injection - hard lump at injection site, red, skin warm to touch
Age: 8.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Dyskinesia, Seizure
Clinical narrative: Patient was observed by mother to be experiencing a seizure. Event occurred around 15 minutes after immunization. Patient was said to have minor "jerking" for 45 seconds and patient hit back on shelf in store and was caught by mother before going completely on the floor. Patient recovered from seizure and was responsive when pharmacist arrived. Patient was observed for additional 20 minutes in pharmacy. Vitals were check and within normal limits. Patient left pharmacy by foot and no other treatment was administered,
Age: 8.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Loss of consciousness, Seizure
Clinical narrative: Patient was observed by mother to be experiencing a seizure. Event occurred around 15 minutes after immunization. Patient was said to have minor "jerking" for 45 seconds and patient hit back on shelf in store and was caught by mother before going completely on the floor. Patient recovered from seizure and was responsive when pharmacist arrived. Patient was observed for additional 20 minutes in pharmacy. Vitals were check and within normal limits. Patient left pharmacy by foot and no other treatment was administered,
Age: 8.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Dyskinesia, Seizure
Clinical narrative: So patient got his shot first. Then older brother and mom got flu shots after. So I told them to sit in the chairs while I got the documents from the pharmacist but the boys didn?t sit they went to find snacks. When mom arrived to the chip aisle. Patient was luckily standing in front of mom and she noticed he had lost consciousness and caught him before he hit his head. Mom lowered him to the floor on her lap and he started to seize in her lap for a minute. Mom told older brother to run back to the pharmacy and get help.  Yes it was a seizer and it was within 10 minutes after receiving the Covid 19 vaccine. It had nothing to do with the chip aisle it just happened in the chip aisle.
Age: 8.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Loss of consciousness, Seizure
Clinical narrative: So patient got his shot first. Then older brother and mom got flu shots after. So I told them to sit in the chairs while I got the documents from the pharmacist but the boys didn?t sit they went to find snacks. When mom arrived to the chip aisle. Patient was luckily standing in front of mom and she noticed he had lost consciousness and caught him before he hit his head. Mom lowered him to the floor on her lap and he started to seize in her lap for a minute. Mom told older brother to run back to the pharmacy and get help.  Yes it was a seizer and it was within 10 minutes after receiving the Covid 19 vaccine. It had nothing to do with the chip aisle it just happened in the chip aisle.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Extra dose administered, No adverse event
Clinical narrative: Vaccine booster administered on 11/12/2021, expiration date was 11/7/202.  Mistook expiration date to be 11/17/2021.  No adverse event or outcome to recipient.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: severe tinnitus about 5 days after tinnitus. after 14 days the tinnitus was not as bad.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea haemorrhagic
Clinical narrative: Patient states that after receiving his vaccine, he started having bloody diarrhea that lasted one week. He was instructed to call EMS and be taking to ER. Patient was anemic at ER, received treatment, then was discharged. Patient still weak at this time.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Given 0.3 ML dose for 12 and older.  Dose for 5-11yrs is 0.2 ml
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Eructation, Piloerection, Spinal pain
Clinical narrative: Within 6 minutes of receiving the vaccine, I got a slow moving pain down my thoracic spine and started to continuously belch. I also have what feels like "goose bumps" from cheek to cheek and on my upper lip. The pain has subsided but the belching and goose bumps have not and I am now about 50 minutes post vaccine. The same thing happened with my first dose but I did not think that it was the vaccine. Tonight confirmed that it was. My first dose was given on 3/19/21 and the lot number was 047A21P. I did not have symptoms with the second dose.
Age: 73.0
Sex: F
Vaccine: FLU4
Symptoms: Headache, Injection site pain, Neck pain
Clinical narrative: per office, patient reports pain in the shoulder extending up the neck and head over the past month since the shot on the right side (on shot arm)
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Extra dose administered, No adverse event
Clinical narrative: Vaccine booster administered on 11/12/2021, expiration date was 11/7/202.  Mistook expiration date to be 11/17/2021.  No adverse event or outcome to recipient.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Discomfort, Grip strength decreased, Inflammation, Joint stiffness
Clinical narrative: Extremely swollen lymph glands under the left armpit. Extreme stiffness and pain in the left and right elbow with the majority of discomfort on the left side. This has not resolved on the left side while some improvement has been made on the right. OTC pain medicine is ineffective. I have been prescribed one round of menthyleprednisone 20 MG once a day for five days to combat inflammation with no long term effect. I still have the stiffness and pain and am losing the grip strength in my left arm.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Extremely swollen lymph glands under the left armpit. Extreme stiffness and pain in the left and right elbow with the majority of discomfort on the left side. This has not resolved on the left side while some improvement has been made on the right. OTC pain medicine is ineffective. I have been prescribed one round of menthyleprednisone 20 MG once a day for five days to combat inflammation with no long term effect. I still have the stiffness and pain and am losing the grip strength in my left arm.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Balance disorder, Chills, Headache, Influenza like illness
Clinical narrative: I had fairly severe flu like symptoms within 8 to 10 hours or so after the booster (3rd) shot of the same type (Pfizer) Covid vaccine. I had zero side effects from either of the first 2 shots in my series of 3. They have all been properly spaced apart, the first shot given 1/29/21 second 2/19/21 and the booster given 11/3/21. The reason for this report is that in addition to the flu like symptoms of fever, chills, headache and joint pains I also had and have muscle spasms, electric  pin needle like sensations, difficulty with balance, abnormal headache ((unlike any experienced before) facial twitches. I ha seen a dr and am going to be seeing a specialist.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms, Muscle twitching, Paraesthesia, Pyrexia
Clinical narrative: I had fairly severe flu like symptoms within 8 to 10 hours or so after the booster (3rd) shot of the same type (Pfizer) Covid vaccine. I had zero side effects from either of the first 2 shots in my series of 3. They have all been properly spaced apart, the first shot given 1/29/21 second 2/19/21 and the booster given 11/3/21. The reason for this report is that in addition to the flu like symptoms of fever, chills, headache and joint pains I also had and have muscle spasms, electric  pin needle like sensations, difficulty with balance, abnormal headache ((unlike any experienced before) facial twitches. I ha seen a dr and am going to be seeing a specialist.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Limb discomfort
Clinical narrative: 55 year old female client arrived to vaccination site requesting Booster dose of Pfizer vaccine.  Client reports that a few days after receiving 2nd Pfizer dose, she began to experience minimal arm discomfort upon opening and closing of fist.  Client reports that discomfort is not debilitating, lasts for a minute and subsides.  Client reports that discomfort continues to occur occasionally present day.  Elevated issue to Clinical Supervisor, who receives approval from Dr. to administer Pfizer booster, and recommends client to follow up with Primary Care Physician regarding arm discomfort.  Client verbalizes understanding, and provides consent to receive booster dose.  Pfizer Booster administered by RN to client's left arm on 11/13/2021 at approximately 2:57 PM, Lot # FF8841.   VAERS completed on 11/19/2021.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On 11/3/2021 it was discovered the vaccine administered on 10/22/2021 had been stored in the freezer longer than the recommended 14 days. Patient did not have an adverse event.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Hyperhidrosis
Clinical narrative: Pt c/o flushing/sweating and dizziness after vaccination. Vitals: 128/79, 70, 16 Pt given juice and crackers. Pt stable and released from the vaccination site.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blepharospasm, Cardiac flutter
Clinical narrative: I have been experiencing left eyelid twitching that started approximately 1 week after getting the shot (11/11/21). I have been having heart fluttering for the last few days starting on 11/15/21 with feelings of anxiety. I usually never get anxiety out of the blue this happens when the heart starts to flutter.  I have not mentioned my symptoms to my doctor yet.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Atelectasis, Blood culture, Blood magnesium normal, Blood sodium decreased
Clinical narrative: COVID Breakthrough  Moderna Dose 1 2/12/21 (016M20A) Moderna Dose 2 3/12/21 (029A21A) COVID Positive 8/19/21  8/19/21: The patient is a 66-year-old male who presents the emergency department today with complaints of worsening shortness of breath, fever, and weakness since 08/09.  The patient has a past medical history significant for COPD, chronic hypoxic respiratory failure on continuous 2-3 liter/minute supplemental O2, history of pneumonia, and history of smoking-quit.  Of note, patient follows with pulmonology outpatient and has been calling office for COPD exacerbation treatment every month, given prednisone burst on 06/22, 7/20, and Z-Pak on 08/11.  Patient fully vaccinated with Moderna COVID-19 vaccine.  On arrival to the ED, the patient's temperature is 101.4° F, heart rate 91, respiratory rate 19, saturating 86% on 5 L supplemental O2 via nasal cannula subsequently requiring increased oxygen at 7 L, then BiPAP mask with blood pressure 122/86 and 6/10 severity chest pain with cough.  The patient's laboratory studies were significant for COVID-19 rapid AG positive, Na 133, mg 1.5, CRP 4.8, D-dimer 0.62 age adjusted normal.  Blood cultures obtained x2.  Chest x-ray shows unchanged scarring at right lung base in airspace disease or atelectasis at left lung base.  CT chest shows mild interstitial thickening and ground-glass opacification compatible with viral pneumonia; right upper lobe nodule seen on prior exam resolved; centrilobular emphysema.  EKG shows normal sinus rhythm, heart rate 96, QTC 439 with left anterior fascicular block and nonspecific ST abnormality. The patient was administered acetaminophen 650 mg p.o., NS IV x1 L, levofloxacin 750 mg IV, Decadron 6 mg IV, DuoNeb 6 mL, and albuterol 6 mL in the emergency department. The patient is seen in the emergency department laying in bed currently on 7 L supplemental O2 via nasal cannula with BiPAP at the bedside.  The patient reports he started feeling bad on 08/09.  He reports that 1 of his roommates has been difficult to convince to get vaccinated and he believes that he likely was exposed from him.  He does have a history of positive sputum culture with Pseudomonas in the past.  He is frustrated that he was fully vaccinated and is now hospitalized with COVID-19, we did discuss that his frequent prednisone prescriptions could have made him more immunosuppressed and we have seen more COVID-19 in fully vaccinated patient's who were immunosuppressed.  8/23/21: PT was admitted and given treatment for COVID pneumonia with with IV antibiotics, steroids, bronchodilator therapy.  Encouraged p.o. intake. Monitored and corrected electrolytes. Patient seen and examined on the day of discharge. States he feels well and voiced readiness to be discharged home. He will be discharged home to continue course of po levaquin and steroid. Total time spent on the discharge process 40 minutes.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Bundle branch block left, C-reactive protein increased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: COVID Breakthrough  Moderna Dose 1 2/12/21 (016M20A) Moderna Dose 2 3/12/21 (029A21A) COVID Positive 8/19/21  8/19/21: The patient is a 66-year-old male who presents the emergency department today with complaints of worsening shortness of breath, fever, and weakness since 08/09.  The patient has a past medical history significant for COPD, chronic hypoxic respiratory failure on continuous 2-3 liter/minute supplemental O2, history of pneumonia, and history of smoking-quit.  Of note, patient follows with pulmonology outpatient and has been calling office for COPD exacerbation treatment every month, given prednisone burst on 06/22, 7/20, and Z-Pak on 08/11.  Patient fully vaccinated with Moderna COVID-19 vaccine.  On arrival to the ED, the patient's temperature is 101.4° F, heart rate 91, respiratory rate 19, saturating 86% on 5 L supplemental O2 via nasal cannula subsequently requiring increased oxygen at 7 L, then BiPAP mask with blood pressure 122/86 and 6/10 severity chest pain with cough.  The patient's laboratory studies were significant for COVID-19 rapid AG positive, Na 133, mg 1.5, CRP 4.8, D-dimer 0.62 age adjusted normal.  Blood cultures obtained x2.  Chest x-ray shows unchanged scarring at right lung base in airspace disease or atelectasis at left lung base.  CT chest shows mild interstitial thickening and ground-glass opacification compatible with viral pneumonia; right upper lobe nodule seen on prior exam resolved; centrilobular emphysema.  EKG shows normal sinus rhythm, heart rate 96, QTC 439 with left anterior fascicular block and nonspecific ST abnormality. The patient was administered acetaminophen 650 mg p.o., NS IV x1 L, levofloxacin 750 mg IV, Decadron 6 mg IV, DuoNeb 6 mL, and albuterol 6 mL in the emergency department. The patient is seen in the emergency department laying in bed currently on 7 L supplemental O2 via nasal cannula with BiPAP at the bedside.  The patient reports he started feeling bad on 08/09.  He reports that 1 of his roommates has been difficult to convince to get vaccinated and he believes that he likely was exposed from him.  He does have a history of positive sputum culture with Pseudomonas in the past.  He is frustrated that he was fully vaccinated and is now hospitalized with COVID-19, we did discuss that his frequent prednisone prescriptions could have made him more immunosuppressed and we have seen more COVID-19 in fully vaccinated patient's who were immunosuppressed.  8/23/21: PT was admitted and given treatment for COVID pneumonia with with IV antibiotics, steroids, bronchodilator therapy.  Encouraged p.o. intake. Monitored and corrected electrolytes. Patient seen and examined on the day of discharge. States he feels well and voiced readiness to be discharged home. He will be discharged home to continue course of po levaquin and steroid. Total time spent on the discharge process 40 minutes.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chronic obstructive pulmonary disease, Computerised tomogram thorax abnormal, Condition aggravated, Cough
Clinical narrative: COVID Breakthrough  Moderna Dose 1 2/12/21 (016M20A) Moderna Dose 2 3/12/21 (029A21A) COVID Positive 8/19/21  8/19/21: The patient is a 66-year-old male who presents the emergency department today with complaints of worsening shortness of breath, fever, and weakness since 08/09.  The patient has a past medical history significant for COPD, chronic hypoxic respiratory failure on continuous 2-3 liter/minute supplemental O2, history of pneumonia, and history of smoking-quit.  Of note, patient follows with pulmonology outpatient and has been calling office for COPD exacerbation treatment every month, given prednisone burst on 06/22, 7/20, and Z-Pak on 08/11.  Patient fully vaccinated with Moderna COVID-19 vaccine.  On arrival to the ED, the patient's temperature is 101.4° F, heart rate 91, respiratory rate 19, saturating 86% on 5 L supplemental O2 via nasal cannula subsequently requiring increased oxygen at 7 L, then BiPAP mask with blood pressure 122/86 and 6/10 severity chest pain with cough.  The patient's laboratory studies were significant for COVID-19 rapid AG positive, Na 133, mg 1.5, CRP 4.8, D-dimer 0.62 age adjusted normal.  Blood cultures obtained x2.  Chest x-ray shows unchanged scarring at right lung base in airspace disease or atelectasis at left lung base.  CT chest shows mild interstitial thickening and ground-glass opacification compatible with viral pneumonia; right upper lobe nodule seen on prior exam resolved; centrilobular emphysema.  EKG shows normal sinus rhythm, heart rate 96, QTC 439 with left anterior fascicular block and nonspecific ST abnormality. The patient was administered acetaminophen 650 mg p.o., NS IV x1 L, levofloxacin 750 mg IV, Decadron 6 mg IV, DuoNeb 6 mL, and albuterol 6 mL in the emergency department. The patient is seen in the emergency department laying in bed currently on 7 L supplemental O2 via nasal cannula with BiPAP at the bedside.  The patient reports he started feeling bad on 08/09.  He reports that 1 of his roommates has been difficult to convince to get vaccinated and he believes that he likely was exposed from him.  He does have a history of positive sputum culture with Pseudomonas in the past.  He is frustrated that he was fully vaccinated and is now hospitalized with COVID-19, we did discuss that his frequent prednisone prescriptions could have made him more immunosuppressed and we have seen more COVID-19 in fully vaccinated patient's who were immunosuppressed.  8/23/21: PT was admitted and given treatment for COVID pneumonia with with IV antibiotics, steroids, bronchodilator therapy.  Encouraged p.o. intake. Monitored and corrected electrolytes. Patient seen and examined on the day of discharge. States he feels well and voiced readiness to be discharged home. He will be discharged home to continue course of po levaquin and steroid. Total time spent on the discharge process 40 minutes.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram QT interval, Electrocardiogram ST-T change, Electrocardiogram abnormal, Electrolyte imbalance
Clinical narrative: COVID Breakthrough  Moderna Dose 1 2/12/21 (016M20A) Moderna Dose 2 3/12/21 (029A21A) COVID Positive 8/19/21  8/19/21: The patient is a 66-year-old male who presents the emergency department today with complaints of worsening shortness of breath, fever, and weakness since 08/09.  The patient has a past medical history significant for COPD, chronic hypoxic respiratory failure on continuous 2-3 liter/minute supplemental O2, history of pneumonia, and history of smoking-quit.  Of note, patient follows with pulmonology outpatient and has been calling office for COPD exacerbation treatment every month, given prednisone burst on 06/22, 7/20, and Z-Pak on 08/11.  Patient fully vaccinated with Moderna COVID-19 vaccine.  On arrival to the ED, the patient's temperature is 101.4° F, heart rate 91, respiratory rate 19, saturating 86% on 5 L supplemental O2 via nasal cannula subsequently requiring increased oxygen at 7 L, then BiPAP mask with blood pressure 122/86 and 6/10 severity chest pain with cough.  The patient's laboratory studies were significant for COVID-19 rapid AG positive, Na 133, mg 1.5, CRP 4.8, D-dimer 0.62 age adjusted normal.  Blood cultures obtained x2.  Chest x-ray shows unchanged scarring at right lung base in airspace disease or atelectasis at left lung base.  CT chest shows mild interstitial thickening and ground-glass opacification compatible with viral pneumonia; right upper lobe nodule seen on prior exam resolved; centrilobular emphysema.  EKG shows normal sinus rhythm, heart rate 96, QTC 439 with left anterior fascicular block and nonspecific ST abnormality. The patient was administered acetaminophen 650 mg p.o., NS IV x1 L, levofloxacin 750 mg IV, Decadron 6 mg IV, DuoNeb 6 mL, and albuterol 6 mL in the emergency department. The patient is seen in the emergency department laying in bed currently on 7 L supplemental O2 via nasal cannula with BiPAP at the bedside.  The patient reports he started feeling bad on 08/09.  He reports that 1 of his roommates has been difficult to convince to get vaccinated and he believes that he likely was exposed from him.  He does have a history of positive sputum culture with Pseudomonas in the past.  He is frustrated that he was fully vaccinated and is now hospitalized with COVID-19, we did discuss that his frequent prednisone prescriptions could have made him more immunosuppressed and we have seen more COVID-19 in fully vaccinated patient's who were immunosuppressed.  8/23/21: PT was admitted and given treatment for COVID pneumonia with with IV antibiotics, steroids, bronchodilator therapy.  Encouraged p.o. intake. Monitored and corrected electrolytes. Patient seen and examined on the day of discharge. States he feels well and voiced readiness to be discharged home. He will be discharged home to continue course of po levaquin and steroid. Total time spent on the discharge process 40 minutes.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Emphysema, Exposure to SARS-CoV-2, Feeling abnormal, Fibrin D dimer, Frustration tolerance decreased
Clinical narrative: COVID Breakthrough  Moderna Dose 1 2/12/21 (016M20A) Moderna Dose 2 3/12/21 (029A21A) COVID Positive 8/19/21  8/19/21: The patient is a 66-year-old male who presents the emergency department today with complaints of worsening shortness of breath, fever, and weakness since 08/09.  The patient has a past medical history significant for COPD, chronic hypoxic respiratory failure on continuous 2-3 liter/minute supplemental O2, history of pneumonia, and history of smoking-quit.  Of note, patient follows with pulmonology outpatient and has been calling office for COPD exacerbation treatment every month, given prednisone burst on 06/22, 7/20, and Z-Pak on 08/11.  Patient fully vaccinated with Moderna COVID-19 vaccine.  On arrival to the ED, the patient's temperature is 101.4° F, heart rate 91, respiratory rate 19, saturating 86% on 5 L supplemental O2 via nasal cannula subsequently requiring increased oxygen at 7 L, then BiPAP mask with blood pressure 122/86 and 6/10 severity chest pain with cough.  The patient's laboratory studies were significant for COVID-19 rapid AG positive, Na 133, mg 1.5, CRP 4.8, D-dimer 0.62 age adjusted normal.  Blood cultures obtained x2.  Chest x-ray shows unchanged scarring at right lung base in airspace disease or atelectasis at left lung base.  CT chest shows mild interstitial thickening and ground-glass opacification compatible with viral pneumonia; right upper lobe nodule seen on prior exam resolved; centrilobular emphysema.  EKG shows normal sinus rhythm, heart rate 96, QTC 439 with left anterior fascicular block and nonspecific ST abnormality. The patient was administered acetaminophen 650 mg p.o., NS IV x1 L, levofloxacin 750 mg IV, Decadron 6 mg IV, DuoNeb 6 mL, and albuterol 6 mL in the emergency department. The patient is seen in the emergency department laying in bed currently on 7 L supplemental O2 via nasal cannula with BiPAP at the bedside.  The patient reports he started feeling bad on 08/09.  He reports that 1 of his roommates has been difficult to convince to get vaccinated and he believes that he likely was exposed from him.  He does have a history of positive sputum culture with Pseudomonas in the past.  He is frustrated that he was fully vaccinated and is now hospitalized with COVID-19, we did discuss that his frequent prednisone prescriptions could have made him more immunosuppressed and we have seen more COVID-19 in fully vaccinated patient's who were immunosuppressed.  8/23/21: PT was admitted and given treatment for COVID pneumonia with with IV antibiotics, steroids, bronchodilator therapy.  Encouraged p.o. intake. Monitored and corrected electrolytes. Patient seen and examined on the day of discharge. States he feels well and voiced readiness to be discharged home. He will be discharged home to continue course of po levaquin and steroid. Total time spent on the discharge process 40 minutes.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Interstitial lung disease, Lung disorder, Lung opacity, Pneumonia viral, Positive airway pressure therapy
Clinical narrative: COVID Breakthrough  Moderna Dose 1 2/12/21 (016M20A) Moderna Dose 2 3/12/21 (029A21A) COVID Positive 8/19/21  8/19/21: The patient is a 66-year-old male who presents the emergency department today with complaints of worsening shortness of breath, fever, and weakness since 08/09.  The patient has a past medical history significant for COPD, chronic hypoxic respiratory failure on continuous 2-3 liter/minute supplemental O2, history of pneumonia, and history of smoking-quit.  Of note, patient follows with pulmonology outpatient and has been calling office for COPD exacerbation treatment every month, given prednisone burst on 06/22, 7/20, and Z-Pak on 08/11.  Patient fully vaccinated with Moderna COVID-19 vaccine.  On arrival to the ED, the patient's temperature is 101.4° F, heart rate 91, respiratory rate 19, saturating 86% on 5 L supplemental O2 via nasal cannula subsequently requiring increased oxygen at 7 L, then BiPAP mask with blood pressure 122/86 and 6/10 severity chest pain with cough.  The patient's laboratory studies were significant for COVID-19 rapid AG positive, Na 133, mg 1.5, CRP 4.8, D-dimer 0.62 age adjusted normal.  Blood cultures obtained x2.  Chest x-ray shows unchanged scarring at right lung base in airspace disease or atelectasis at left lung base.  CT chest shows mild interstitial thickening and ground-glass opacification compatible with viral pneumonia; right upper lobe nodule seen on prior exam resolved; centrilobular emphysema.  EKG shows normal sinus rhythm, heart rate 96, QTC 439 with left anterior fascicular block and nonspecific ST abnormality. The patient was administered acetaminophen 650 mg p.o., NS IV x1 L, levofloxacin 750 mg IV, Decadron 6 mg IV, DuoNeb 6 mL, and albuterol 6 mL in the emergency department. The patient is seen in the emergency department laying in bed currently on 7 L supplemental O2 via nasal cannula with BiPAP at the bedside.  The patient reports he started feeling bad on 08/09.  He reports that 1 of his roommates has been difficult to convince to get vaccinated and he believes that he likely was exposed from him.  He does have a history of positive sputum culture with Pseudomonas in the past.  He is frustrated that he was fully vaccinated and is now hospitalized with COVID-19, we did discuss that his frequent prednisone prescriptions could have made him more immunosuppressed and we have seen more COVID-19 in fully vaccinated patient's who were immunosuppressed.  8/23/21: PT was admitted and given treatment for COVID pneumonia with with IV antibiotics, steroids, bronchodilator therapy.  Encouraged p.o. intake. Monitored and corrected electrolytes. Patient seen and examined on the day of discharge. States he feels well and voiced readiness to be discharged home. He will be discharged home to continue course of po levaquin and steroid. Total time spent on the discharge process 40 minutes.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary fibrosis, Pulmonary mass, Pyrexia, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID Breakthrough  Moderna Dose 1 2/12/21 (016M20A) Moderna Dose 2 3/12/21 (029A21A) COVID Positive 8/19/21  8/19/21: The patient is a 66-year-old male who presents the emergency department today with complaints of worsening shortness of breath, fever, and weakness since 08/09.  The patient has a past medical history significant for COPD, chronic hypoxic respiratory failure on continuous 2-3 liter/minute supplemental O2, history of pneumonia, and history of smoking-quit.  Of note, patient follows with pulmonology outpatient and has been calling office for COPD exacerbation treatment every month, given prednisone burst on 06/22, 7/20, and Z-Pak on 08/11.  Patient fully vaccinated with Moderna COVID-19 vaccine.  On arrival to the ED, the patient's temperature is 101.4° F, heart rate 91, respiratory rate 19, saturating 86% on 5 L supplemental O2 via nasal cannula subsequently requiring increased oxygen at 7 L, then BiPAP mask with blood pressure 122/86 and 6/10 severity chest pain with cough.  The patient's laboratory studies were significant for COVID-19 rapid AG positive, Na 133, mg 1.5, CRP 4.8, D-dimer 0.62 age adjusted normal.  Blood cultures obtained x2.  Chest x-ray shows unchanged scarring at right lung base in airspace disease or atelectasis at left lung base.  CT chest shows mild interstitial thickening and ground-glass opacification compatible with viral pneumonia; right upper lobe nodule seen on prior exam resolved; centrilobular emphysema.  EKG shows normal sinus rhythm, heart rate 96, QTC 439 with left anterior fascicular block and nonspecific ST abnormality. The patient was administered acetaminophen 650 mg p.o., NS IV x1 L, levofloxacin 750 mg IV, Decadron 6 mg IV, DuoNeb 6 mL, and albuterol 6 mL in the emergency department. The patient is seen in the emergency department laying in bed currently on 7 L supplemental O2 via nasal cannula with BiPAP at the bedside.  The patient reports he started feeling bad on 08/09.  He reports that 1 of his roommates has been difficult to convince to get vaccinated and he believes that he likely was exposed from him.  He does have a history of positive sputum culture with Pseudomonas in the past.  He is frustrated that he was fully vaccinated and is now hospitalized with COVID-19, we did discuss that his frequent prednisone prescriptions could have made him more immunosuppressed and we have seen more COVID-19 in fully vaccinated patient's who were immunosuppressed.  8/23/21: PT was admitted and given treatment for COVID pneumonia with with IV antibiotics, steroids, bronchodilator therapy.  Encouraged p.o. intake. Monitored and corrected electrolytes. Patient seen and examined on the day of discharge. States he feels well and voiced readiness to be discharged home. He will be discharged home to continue course of po levaquin and steroid. Total time spent on the discharge process 40 minutes.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: There was a temperature excursion on this vaccine.  It remained in the freezer longer than 2 weeks.  The recommended time frame to be in the freezer.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Syringe issue
Clinical narrative: VanishPoint syringe malfunction resulting in loss of more than half the dose.  Patient understood and re-vaccinated without incident.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Erythema, Peripheral swelling, Pruritus
Clinical narrative: Arm got very itchy, swelling and redness about the size of a baseball, and a severe bruise
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, C-reactive protein increased, Differential white blood cell count abnormal, Fatigue, Full blood count normal
Clinical narrative: Severe increase in activity of rheumatoid arthritis symptoms: arthralgia, swelling, and fatigue within week of vaccination. Symptoms have decreased in severity following aggressive medication treatment but are persisting through 7 months post-dose. Disease was previously well controlled for approximately 5 years.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphocyte percentage decreased, Neutrophil percentage increased, Red blood cell sedimentation rate increased, Rheumatoid arthritis, Swelling
Clinical narrative: Severe increase in activity of rheumatoid arthritis symptoms: arthralgia, swelling, and fatigue within week of vaccination. Symptoms have decreased in severity following aggressive medication treatment but are persisting through 7 months post-dose. Disease was previously well controlled for approximately 5 years.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Gave 1 week early
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Extra dose administered, No adverse event
Clinical narrative: Vaccine booster administered on 11/12/2021, expiration date was 11/7/202.  Mistook expiration date to be 11/17/2021.  No adverse event or outcome to recipient.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Horrible, throbbing head-ache (felt like my head was going to explode) I had the same head-ache issues after the first 2 injections, but did not realize that they were caused by the Covid shots until I experienced the same symptoms after this  booster shot
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Basedow's disease
Clinical narrative: I NOW HAVE  GRAVES DISEASE - DUE TO THIS VACCINE!! I WILL NOW BE ON MEDICATION FOR NO LESS THAN ONE YEAR - OR FOR THE REST OF MY LIFE! THIS IS UNACCEPTABLE. THE PUBLIC HAS THE RIGHT TO KNOW!
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On 11/3 it was discovered that vaccine which was administered that day had been stored in the freezer longer than the recommended 14 days.  Pt did not have an adverse event.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Hypoxia, Intensive care
Clinical narrative: COVID Breakthrough  J&J Dose 3/23/21 (1808609) COVID Positive 8/11/21 Presented to and discharged from ED 8/11/21:  8/12/21: The patient presents with SOB/COVID +.  Onset: 08/12/2021 .  Location: Respiratory. Context: A 73 y/o male presents to the ED with SOB. Patient is COVID positive and was diagnosed yesterday. Patient had the Regeneron infusion today. Pt also dialysed. Patient's pulse ox was 88% at home so he came to the Hospital. Patient is feeling sob, he has a cough and feels feverish. Patient is borderline DM, on Dialysis and has HTN. Patient did have the Johnson and Johnson Vaccine. Pt had PO 82% on arrival to ER and Patient denies chest pain, abdominal pain, N/V, diarrhea, constipation, dysuria, joint pain, headache, dizziness or lightheadedness.  8/23/21: 73-year-old male with a history of ESRD on HD MWF schedule, recent diagnosis of COVID-19 infection, T2 dm admitted for worsening SOB with hypoxia. Initially placed on biapa and optiflow in icu, slowly weaned down to 2 liters at rest and 5 liters with ambulation. he has already received the j and j vaccine, but still tested positive. he received regeneron and dexamethasone, as well as iv antibiotics. he continue his 3x a week dialysis. patient seen by PT and cleared for discharge.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Pyrexia, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID Breakthrough  J&J Dose 3/23/21 (1808609) COVID Positive 8/11/21 Presented to and discharged from ED 8/11/21:  8/12/21: The patient presents with SOB/COVID +.  Onset: 08/12/2021 .  Location: Respiratory. Context: A 73 y/o male presents to the ED with SOB. Patient is COVID positive and was diagnosed yesterday. Patient had the Regeneron infusion today. Pt also dialysed. Patient's pulse ox was 88% at home so he came to the Hospital. Patient is feeling sob, he has a cough and feels feverish. Patient is borderline DM, on Dialysis and has HTN. Patient did have the Johnson and Johnson Vaccine. Pt had PO 82% on arrival to ER and Patient denies chest pain, abdominal pain, N/V, diarrhea, constipation, dysuria, joint pain, headache, dizziness or lightheadedness.  8/23/21: 73-year-old male with a history of ESRD on HD MWF schedule, recent diagnosis of COVID-19 infection, T2 dm admitted for worsening SOB with hypoxia. Initially placed on biapa and optiflow in icu, slowly weaned down to 2 liters at rest and 5 liters with ambulation. he has already received the j and j vaccine, but still tested positive. he received regeneron and dexamethasone, as well as iv antibiotics. he continue his 3x a week dialysis. patient seen by PT and cleared for discharge.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered was in the freezer for more than the recommended time of two weeks.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On 11/3/2021 it was discovered the vaccine administered that day had been stored in the freezer longer than the recommended 14 days. Patient did not have an adverse event.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dry mouth, Nausea, Vomiting
Clinical narrative: Patient had dry mouth, then nausea and vomiting. Felt faint.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Product administered to patient of inappropriate age
Clinical narrative: Patient was 16 years old.....third dose booster
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Conjunctivitis, Culture, Dermatitis, Furuncle
Clinical narrative: Allergic, bacterial conjunctivitis in right eye, skin dermatitis around the eye, onset 11/05/2021 developing into a boil by 11/10/2021 below corner of eye between nose bridge and tear duct.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dialysis, Dysuria, Eye swelling, Face oedema
Clinical narrative: COVID Pfizer Vaccine Adverse Event  Pfizer Dose 1 8/10/21 (EW0179) Pfizer Dose 2 8/31/21 (EW0177)  9/1/21: The patient presents with fever and Pt is a 24 y/o female with a history of hypertension, hypothyroidism, GERD, hemorrhoids, nephritis, restless leg syndrome, seizure, systemic lupus erythematosus, and anemia. Pt is on dialysis and her nephrologist is Dr. She presents today with a fever, headache, puffiness in her eyes, and general weakness. She states that her eyes were getting puffy for the last couple weeks, which has stayed constant. Her fever began yesterday, which her mother states is the reason that she came in to the ED. Pt got her second covid vaccination yesterday and underwent dialysis yesterday as well. Today, the pt had a fever of 101.8 degrees Fahrenheit today. Pt does not make urine and has had no change in volume. She has no known sick contacts and receives an infusion every month. Pt had lemonade today, but has not eaten or drank anything else. She denies any change in appetite. She sees Dr. for her lupus. She did have covid in April. Pt is on immune suppressants and Prednisone. Pt reports having a similar experience when she had covid and was prescribed Prednisone. Pertinent ROS: She denies cough, shortness of breath, dental pain, ear pain, facial pain, nasal congestion, sore throat, vomiting, eye pain, eye drainage, or diarrhea. She does admit to fever, headache, eye swelling, and generalized weakness..  The onset was 1  days ago.  The course/duration of symptoms is worsening.  Associated symptoms: headache.  Temperature is 101.8  Fahrenheit subjective.  Risk factors consist of dialysis patient and Pt is on immuno-suppressants.  Therapy today: see nurses notes.  9/2/2021:  Pt was admitted to observation with planned dialysis to occur morning 9/2. Nephrology consulted, recs made. Losartan held. All BP meds held while hospitalized. Pt underwent dialysis and her sx resolved. patient was revisited in the early afternoon, objective facial edema had resolved.  Nonlabored respirations, clear speech.  Patient stated that she was at her baseline and requested to see charge home.  COVID PCR negative.  This writer contacted Nephrology and they were agreeable with discharge at this time.   On discharge, losartan will be discontinued altogether. Facial edema cause losartan vs 2nd COVID.  Patient is to resume metoprolol tartrate 50 mg b.i.d. and hydralazine 100 mg b.i.d. as this was her home medication prior to hospitalization. To continue dialysis T, TH, Sat.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Periorbital swelling, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: COVID Pfizer Vaccine Adverse Event  Pfizer Dose 1 8/10/21 (EW0179) Pfizer Dose 2 8/31/21 (EW0177)  9/1/21: The patient presents with fever and Pt is a 24 y/o female with a history of hypertension, hypothyroidism, GERD, hemorrhoids, nephritis, restless leg syndrome, seizure, systemic lupus erythematosus, and anemia. Pt is on dialysis and her nephrologist is Dr. She presents today with a fever, headache, puffiness in her eyes, and general weakness. She states that her eyes were getting puffy for the last couple weeks, which has stayed constant. Her fever began yesterday, which her mother states is the reason that she came in to the ED. Pt got her second covid vaccination yesterday and underwent dialysis yesterday as well. Today, the pt had a fever of 101.8 degrees Fahrenheit today. Pt does not make urine and has had no change in volume. She has no known sick contacts and receives an infusion every month. Pt had lemonade today, but has not eaten or drank anything else. She denies any change in appetite. She sees Dr. for her lupus. She did have covid in April. Pt is on immune suppressants and Prednisone. Pt reports having a similar experience when she had covid and was prescribed Prednisone. Pertinent ROS: She denies cough, shortness of breath, dental pain, ear pain, facial pain, nasal congestion, sore throat, vomiting, eye pain, eye drainage, or diarrhea. She does admit to fever, headache, eye swelling, and generalized weakness..  The onset was 1  days ago.  The course/duration of symptoms is worsening.  Associated symptoms: headache.  Temperature is 101.8  Fahrenheit subjective.  Risk factors consist of dialysis patient and Pt is on immuno-suppressants.  Therapy today: see nurses notes.  9/2/2021:  Pt was admitted to observation with planned dialysis to occur morning 9/2. Nephrology consulted, recs made. Losartan held. All BP meds held while hospitalized. Pt underwent dialysis and her sx resolved. patient was revisited in the early afternoon, objective facial edema had resolved.  Nonlabored respirations, clear speech.  Patient stated that she was at her baseline and requested to see charge home.  COVID PCR negative.  This writer contacted Nephrology and they were agreeable with discharge at this time.   On discharge, losartan will be discontinued altogether. Facial edema cause losartan vs 2nd COVID.  Patient is to resume metoprolol tartrate 50 mg b.i.d. and hydralazine 100 mg b.i.d. as this was her home medication prior to hospitalization. To continue dialysis T, TH, Sat.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On 11/3/2021 it was discovered the vaccine administered that day had been stored in the freezer longer than the recommended 14 days. Patient did not have an adverse event.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Medical assistant, administered the wrong vaccine to the wrong client. This client was to have received Moderna for the second dose and received Pfizer. No signs & symptoms noted after waiting 15 minutes as we encouraged.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives with itching appeared on left arm at 7:25 pm and spread to trunk.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient was vaccinated with a vaccine which was stored in the freezer longer than the recommended time. (over two weeks)
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site urticaria
Clinical narrative: Hives and itchiness in the injection site with ~1.5inch radius. This began the day after vaccine although parents were unaware until evening of day 3 when degree of itch prompted complaint. Treatment with topical and oral antihistamine as well as pain medicine for the night.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient was administered a vaccine which was ket in the freezer longer than the 2 week recommended time.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On 11/3 it was discovered that vaccine which was administered that day had been stored in the freezer longer than the recommended 14 days.  Pt did not have an adverse event.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Extra dose administered, No adverse event
Clinical narrative: Vaccine booster administered on 11/12/2021, expiration date was 11/7/202.  Mistook expiration date to be 11/17/2021.  No adverse event or outcome to recipient.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On 11/3/2021, it was discovered the vaccine administered that day had been stored in the freezer longer than the recommended 14 days. Patient did not have an adverse event.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Rash
Clinical narrative: generalized rash, sharp chest pains, mild shortness of breath noted morning after receipt of vaccine.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient was administered a vaccine which was kept in the freezer longer than the 2  week recommended time.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On 11/3 it was discovered that vaccine which was administered that day had been stored in the freezer longer than the recommended 14 days.  Pt did not have an adverse event.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash
Clinical narrative: Multiple bumps around injection site, itchiness